TAK1-mediated Autophagy and Fatty Acid Oxidation Prevent Hepatosteatosis and Tumorigenesis.
Sayaka Inokuchi-Shimizu,Eek Joong Park,Yoon Seok Roh,Ling Yang,Bi Zhang,Jingyi Song,Shuang Liang,Michael Pimienta,Koji Taniguchi,Xuefeng Wu,Kinji Asahina,William Lagakos,Mason R. Mackey,Shizuo Akira,Mark H. Ellisman,Dorothy D. Sears,Jerrold M. Olefsky,Michael Karin,David A. Brenner,Ekihiro Seki
DOI: https://doi.org/10.1172/jci74068
2014-01-01
Abstract:The MAP kinase kinase kinase TGFβ-activated kinase 1 (TAK1) is activated by TLRs, IL-1, TNF, and TGFβ and in turn activates IKK-NF-κB and JNK, which regulate cell survival, growth, tumorigenesis, and metabolism. TAK1 signaling also upregulates AMPK activity and autophagy. Here, we investigated TAK1-dependent regulation of autophagy, lipid metabolism, and tumorigenesis in the liver. Fasted mice with hepatocyte-specific deletion of Tak1 exhibited severe hepatosteatosis with increased mTORC1 activity and suppression of autophagy compared with their WT counterparts. TAK1-deficient hepatocytes exhibited suppressed AMPK activity and autophagy in response to starvation or metformin treatment; however, ectopic activation of AMPK restored autophagy in these cells. Peroxisome proliferator-activated receptor α (PPARα) target genes and β-oxidation, which regulate hepatic lipid degradation, were also suppressed in hepatocytes lacking TAK1. Due to suppression of autophagy and β-oxidation, a high-fat diet challenge aggravated steatohepatitis in mice with hepatocyte-specific deletion of Tak1. Notably, inhibition of mTORC1 restored autophagy and PPARα target gene expression in TAK1-deficient livers, indicating that TAK1 acts upstream of mTORC1. mTORC1 inhibition also suppressed spontaneous liver fibrosis and hepatocarcinogenesis in animals with hepatocyte-specific deletion of Tak1. These data indicate that TAK1 regulates hepatic lipid metabolism and tumorigenesis via the AMPK/mTORC1 axis, affecting both autophagy and PPARα activity.